Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

LinkDoc, a Beijing Cancer Data Company, to Raise up to $500 Million in US IPO 

publication date: Jun 15, 2021

Beijing's LinkDoc Technology, an AI driven healthcare company based on cancer patient data, filed to IPO on the NASDAQ exchange. LinkDoc has been supported by Alibaba. The company structures cancer patient data, which it acquires from 330 top tier China hospitals, to support precision medicine and personalized care. So far, it has longitudinal data on 2.5 million oncology patients and has helped 3.5 million patients. During its most recent 12 months, LinkDoc booked $157 million in revenue and claims to have the largest China market share in its field. LinkDoc may be seeking to raise as much as $500 million. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital